Technologies
Title: | Immunoassay based blood test for detection of Alzheimer’s disease (AD) using plasmonic - fibre optics absorbance biosensor platform (P-FAB) |
Area: | Medical Sciences |
Focus Area: | Molecular Biology, Frugal Innovation |
Status: | Proof of Concept established |
Patent: | IP Status: In process (Immunoassay for the detection of AD) |
Social Benefits: | The product intends to reduce the healthcare burden and improve the quality of life for individuals affected by Alzheimer’s disease. |
Developing Agency: | Healthiverse Wellness Private Limited, Tamil Nadu |
Technology Readiness Index: | TRL 3 |
Brief Description
Description : | The immunoassay-based blood test for detecting Alzheimer’s disease (AD) utilizes the Plasmonic-Fiber Optic Absorbance Biosensor Platform (P-FAB). Addressing the need for a sensitive assay to detect changes in the concentration of the Alzheimer's disease biomarker, Amyloid β 42, the P-FAB platform employs a sandwich assay approach with plasmonic labels on a U-bent fiber optic sensor probe. Effectively measuring biomarker concentrations in pg/ml, P-FAB presents a promising solution for accurate Alzheimer’s disease detection. |